Abstract
Cytochrome P450 enzymes play a key role in the metabolism of pharmaceutical agents. To determine metabolite toxicity, it is necessary to obtain P450 metabolites from various pharmaceutical agents. Here, we describe a bioreactor that is made by immobilizing cytochrome P450 2C9 (CYP2C9) to a poly(methyl methacrylate) surface and, as an alternative to traditional chemical synthesis, can be used to biosynthesize P450 metabolites in a plug flow bioreactor. As part of the development of the CYP2C9 bioreactor, we have studied two different methods of attachment: (1) coupling via the N-terminus using N-hydroxysulfosuccinimide 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and (2) using the Ni(II) chelator 1-acetato-4-benzyl-triazacyclononane to coordinate the enzyme to the surface using a C-terminal histidine tag. Additionally, the propensity for metabolite production of the CYP2C9 proof-of-concept bioreactors as a function of enzyme attachment conditions (e.g., time and enzyme concentration) was examined. Our results show that the immobilization of CYP2C9 enzymes to a PMMA surface represents a viable and alternative approach to the preparation of CYP2C9 metabolites for toxicity testing. Furthermore, the basic approach can be adapted to any cytochrome P450 enzyme and in a high-throughput, automated process.
Similar content being viewed by others
References
Guengerich, F. P. (1991). Journal of Biological Chemistry, 266, 10019–10022.
Hvastkovs, E. G., Schenkman, J. B., & Rusling, J. F. (2012). Annual Review of Analytical Chemistry, 5, 79–105.
Guengerich, F. P. (2006). The AAPS Journal, 8, E101–E111.
Kumar, G. N., & Surapaneni, S. (2001). Medicinal Research Reviews, 21, 397–411.
Baillie, T. A., Cayen, M. N., Fouda, H., Gerson, R. J., Green, J. D., Grossman, S. J., Klunk, L. J., LeBlanc, B., Perkins, D. G., & Shipley, L. A. (2002). Toxicology and Applied Pharmacology, 182, 188–196.
Li, A. P. (2001). Drug Discovery Today, 6, 357–366.
Manyike, P. T., Kharasch, E. D., Kalhorn, T. F., & Slattery, J. T. (2000). Clinical Pharmacology and Therapeutics, 67, 275–282.
Iverson, S. L., & Uetrecht, J. P. (2001). Chemical Research in Toxicology, 14, 175–181.
Stepan, A. F., Walker, D. P., Bauman, J., Price, D. A., Baillie, T. A., Kalgutkar, A. S., & Aleo, M. D. (2011). Chemical Research in Toxicology, 24, 1345–1410.
Sanderson, J., Naisbitt, D., & Park, B. (2006). The AAPS Journal, 8, E55–E64.
Kim, M.-J., Kim, H., Chu, I.-J., Park, J.-S., Shon, J.-H., Liu, K.-H., & Shin, J.-G. (2005). Rapid Commun in Mass Spectrometry, 19, 2651–2658.
Loida, P. J., Sligar, S. G., Paulsen, M. D., Arnold, G. E., & Ornstein, R. L. (1995). Journal of Biological Chemistry, 270, 5326–5330.
Koeller, K. M., & Wong, C.-H. (2001). Nature, 409, 232–240.
Urlacher, V. B., & Eiben, S. (2006). Trends in Biotechnology, 24, 324–330.
Meunier, B., de Visser, S. P., & Shaik, S. (2004). Chemical Reviews, 104, 3947–3980.
Li, Q.-S., Ogawa, J., Schmid, R. D., & Shimizu, S. (2005). Bioscience, Biotechnology, and Biochemistry, 69, 293–300.
Nagel, B., Dellweg, H., & Gierasch, L. M. (1992). Pure and Applied Chemistry, 64, 143–168.
Estavillo, C., Lu, Z., Jansson, I., Schenkman, J. B., & Rusling, J. F. (2006). Biophysical Chemistry, 104, 291–296.
Fantuzzi, A., Capria, E., Mak, L. H., Dodhia, V. R., Sadeghi, S. J., Collins, S., Somers, G., Huq, E., & Gilardi, G. (2010). Analytical Chemistry, 82, 10222–10227.
Krishnan, S., Wasalathanthri, D., Zhao, L., Schenkman, J. B., & Rusling, J. F. (2011). Journal of the American Chemical Society, 133, 1459–1465.
Xu, X., Wei, W., Huang, M., Yao, L., & Liu, S. (2012). Chemical Communications, 48, 7802–7804.
Yang, M., Kabulski, J. L., Wollenberg, L., Chen, X., Lederman, D., Tracy, T. S., Gannett, P. M., & Wu, N. (2009). Drug Metabolism and Disposition, 37, 892–899.
Zhang, Z, Perozziello, G, Boccazzi, P, Sinskey, AJ, Geschke, O, Jensen, KF. (2007). Microbioreactors for bioprocess development. JALA 12(3), 143–151.
Pasirayi, G., Auger, V., Scott, S. M., Rhaman, P. K. S. M., Islam, M., O’Hare, L., & Ali, Z. (2011). Microbiologica Nanosys, 3, 137–160.
Eibl, R., Kaiser, S., Lombriser, R., & Eibl, D. (2010). Applied Microbiology and Biotechnology, 86, 41–49.
Nelson, M. I., Balakrishnan, E., & Sidhu, H. S. (2012). Chemical Engineering Communications, 199, 417–433.
Santek, B., Ivancic, M., Horvat, P., Novak, S., & Maric, V. (2006). Chemical and Biochemical Engineering Quarterly, 20, 389–399.
Hao, D. C., Zhu, P. H., Yang, S. L., & Yang, L. (2006). World Journal of Microbiology and Biotechnology, 22, 1169–1176.
Vail, R. B., Homann, M. J., Hanna, I., & Zaks, A. (2005). Journal of Industrial Microbiology and Biotechnology, 32, 67–74.
Zhang, D. L., Zhang, H. Y., Aranibar, N., Hanson, R., Huang, Y., Cheng, P. T., Wu, S., Bonacorsi, S., Zhu, M. S., Swaminathan, A., & Humphreys, W. G. (2006). Drug Metabolism and Disposition, 34, 267–280.
Rushmore, T. H., Reider, P. J., Slaughter, D., Assang, C., & Shou, M. (2000). Metabolic Engineering, 2, 115–125.
Bader, A., Fruhauf, N., Zech, K., Haverich, A., & Borlak, J. T. (1998). Xenotransplantation, 28, 815–825.
De Bartolo, L., Salerno, S., Curcio, E., Piscioneri, A., Rende, M., Morelli, S., Tasselli, F., Bader, A., & Drioli, E. (2009). Biomaterials, 30, 2531–2543.
van Liempd, S. M., Kool, J., Reinen, J., Schenk, T., Meerman, J. H., Irth, H., & Vermeulen, N. P. (2005). Journal of Chromatography A, 1075, 205–212.
van Liempd, S. M., Kool, J., Meerman, J. H., Irth, H., & Vermeulen, N. P. (2007). Chemical Research in Toxicology, 20, 1825–1832.
Nicoli, R., Bartolini, M., Rudaz, S., Andrisano, V., & Veuthey, J.-L. (2008). Journal of Chromatography A, 1206, 2–10.
Gannett, P. M., Kabulski, J., Perez, F. A., Liu, Z., Lederman, D. L., Locuson, C. W., Ayscue, R. R., Thomsen, N. M., & Tracy, T. S. (2006). Journal of the American Chemical Society, 128, 8374–8375.
Locuson, C. W., Gannett, P. M., & Tracy, T. S. (2006). Archives of Biochemistry and Biophysics, 449, 115–129.
Johnson, D. L., & Martin, L. L. (2005). Journal of the American Chemical Society, 127, 2018–2019.
Locuson, C. W., Wienkers, L. C., Jones, J. P., & Tracy, T. S. (2007). Drug Metabolism and Disposition, 35, 1174–1181.
Sandhu, P., Guo, Z., Baba, T., & Martin, M. V. (1994). Archives of Biochemistry and Biophysics, 309, 168–177.
Wollenberg, L. A., Jett, J. E., Wu, Y., Flora, D. R., Wu, N., Tracy, T. S., and Gannett, P. M. (2012) Nanotechnology 23, 385101 (9 pp).
Osorio-Lozada, A., Surapaneni, S., Skiles, G. L., & Subramanian, R. (2008). Drug Metabolism and Disposition, 36, 234–240.
Acknowledgments
Financial support was provided through NIH GM081348 as well as the WVEPSCOR (HEPC.dsr.09.013) graduate student fellowships in STEM to JK and LW.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wollenberg, L.A., Kabulski, J.L., Powell, M.J. et al. The Use of Immobilized Cytochrome P4502C9 in PMMA-Based Plug Flow Bioreactors for the Production of Drug Metabolites. Appl Biochem Biotechnol 172, 1293–1306 (2014). https://doi.org/10.1007/s12010-013-0537-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-013-0537-z